Literature DB >> 16841198

Enhanced transscleral lontophoretic transport with ion-exchange membrane.

S Kevin Li1, Honggang Zhu, William I Higuchi.   

Abstract

PURPOSE: Transscleral iontophoresis has been recently re-examined for drug delivery to the back of the eye. In conventional iontophoresis, due to the relatively high electromobility of the endogenous competing ions (counterions) relative to that of the drug ion in the tissue barrier, the efficiency of iontophoretic drug delivery is generally low. The objective of the present study was to examine ion-exchange membrane-enhanced transscleral iontophoretic transport in which the ion-exchange membrane in series with the sclera can hinder the transport of the competing counterions and selectively allow the transport of the permeant across the sclera.
METHODS: The physical properties of the Ionac ion-exchange membrane and excised rabbit sclera were determined in equilibrium uptake experiments and in passive and iontophoretic transport experiments with salicylate, tetraethylammonium, urea, and mannitol. Transscleral experiments with the ion-exchange membrane were conducted with salicylate and excised rabbit sclera in vitro. The contribution of electroosmosis to electrotransport during transscleral iontophoresis was assessed with urea and mannitol.
RESULTS: The ion-exchange membrane is highly positively charged and has a small effective pore size. The sclera is relatively porous with a large effective pore size and low pore tortuosity. The sclera is also net negatively charged but this does not significantly affect the transport of small ions. A three-fold steady-state transscleral flux enhancement of salicylate was observed in ion-exchange membrane-enhanced iontophoresis over conventional transscleral iontophoresis without the membrane. Such enhancement was relatively independent of the applied electric current density and the thickness of the studied ion-exchange membrane assembly. Although the ion-exchange membrane altered transscleral electroosmosis, the contribution of electroosmosis to electrotransport was not significant.
CONCLUSIONS: The present study has demonstrated the potential of ion-exchange membranes for enhancing iontophoretic transport and drug delivery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16841198     DOI: 10.1007/s11095-006-9010-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  20 in total

Review 1.  Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.

Authors:  M R Prausnitz; J S Noonan
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

2.  Tolerance of ocular iontophoresis in healthy volunteers.

Authors:  Thomas M Parkinson; Elizabeth Ferguson; Salvatore Febbraro; Arash Bakhtyari; Martin King; Mohan Mundasad
Journal:  J Ocul Pharmacol Ther       Date:  2003-04       Impact factor: 2.671

3.  Hindered diffusion of polar molecules through and effective pore radii estimates of intact and ethanol treated human epidermal membrane.

Authors:  K D Peck; A H Ghanem; W I Higuchi
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

4.  Model analysis of flux enhancement across hairless mouse skin induced by chemical permeation enhancers.

Authors:  Ning He; Kevin S Warner; William I Higuchi; S Kevin Li
Journal:  Int J Pharm       Date:  2005-04-20       Impact factor: 5.875

5.  Influence of asymmetric donor-receiver ion concentration upon transscleral iontophoretic transport.

Authors:  S Kevin Li; Yanhui Zhang; Honggang Zhu; William I Higuchi; Henry S White
Journal:  J Pharm Sci       Date:  2005-04       Impact factor: 3.534

6.  Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.

Authors:  F F Behar-Cohen; A El Aouni; S Gautier; G David; J Davis; P Chapon; J M Parel
Journal:  Exp Eye Res       Date:  2002-01       Impact factor: 3.467

7.  Assessment of subconjunctival delivery with model ionic permeants and magnetic resonance imaging.

Authors:  S Kevin Li; Sarah A Molokhia; Eun-Kee Jeong
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

8.  Iontophoretic transport across a multiple membrane system.

Authors:  Sarah A Molokhia; Yanhui Zhang; William I Higuchi; S Kevin Li
Journal:  J Pharm Sci       Date:  2008-01       Impact factor: 3.534

9.  Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning.

Authors:  T W Olsen; H F Edelhauser; J I Lim; D H Geroski
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-08       Impact factor: 4.799

10.  Ocular aspirin distribution: a comparison of intravenous, topical, and coulomb-controlled iontophoresis administration.

Authors:  Monika Voigt; Martina Kralinger; Gerhard Kieselbach; Pascal Chapon; Scott Anagnoste; Brandy Hayden; Jean-Marie Parel
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-10       Impact factor: 4.799

View more
  4 in total

1.  Iontophoretic transport across a multiple membrane system.

Authors:  Sarah A Molokhia; Yanhui Zhang; William I Higuchi; S Kevin Li
Journal:  J Pharm Sci       Date:  2008-01       Impact factor: 3.534

2.  Examination of barriers and barrier alteration in transscleral iontophoresis.

Authors:  Sarah A Molokhia; Eun-Kee Jeong; William I Higuchi; S Kevin Li
Journal:  J Pharm Sci       Date:  2008-02       Impact factor: 3.534

3.  Ion-exchange membrane assisted transdermal iontophoretic delivery of salicylate and acyclovir.

Authors:  Qingfang Xu; Sarah A Ibrahim; William I Higuchi; S Kevin Li
Journal:  Int J Pharm       Date:  2008-11-11       Impact factor: 5.875

4.  Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability.

Authors:  S Nicoli; G Ferrari; M Quarta; C Macaluso; P Govoni; D Dallatana; P Santi
Journal:  Mol Vis       Date:  2009-02-06       Impact factor: 2.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.